These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2060433)

  • 1. Diabetes Intervention Study. Multi-intervention trial in newly diagnosed NIDDM.
    Hanefeld M; Fischer S; Schmechel H; Rothe G; Schulze J; Dude H; Schwanebeck U; Julius U
    Diabetes Care; 1991 Apr; 14(4):308-17. PubMed ID: 2060433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early lifestyle intervention in patients with non-insulin-dependent diabetes mellitus and impaired glucose tolerance.
    Uusitupa MI
    Ann Med; 1996 Oct; 28(5):445-9. PubMed ID: 8949977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.
    Holman RR; Coleman RL; Chan JCN; Chiasson JL; Feng H; Ge J; Gerstein HC; Gray R; Huo Y; Lang Z; McMurray JJ; Rydén L; Schröder S; Sun Y; Theodorakis MJ; Tendera M; Tucker L; Tuomilehto J; Wei Y; Yang W; Wang D; Hu D; Pan C;
    Lancet Diabetes Endocrinol; 2017 Nov; 5(11):877-886. PubMed ID: 28917545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fish oil supplements in NIDDM subjects. Controlled study.
    Hendra TJ; Britton ME; Roper DR; Wagaine-Twabwe D; Jeremy JY; Dandona P; Haines AP; Yudkin JS
    Diabetes Care; 1990 Aug; 13(8):821-9. PubMed ID: 2209315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.
    Keech A; Simes RJ; Barter P; Best J; Scott R; Taskinen MR; Forder P; Pillai A; Davis T; Glasziou P; Drury P; Kesäniemi YA; Sullivan D; Hunt D; Colman P; d'Emden M; Whiting M; Ehnholm C; Laakso M;
    Lancet; 2005 Nov; 366(9500):1849-61. PubMed ID: 16310551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study.
    Koskinen P; Mänttäri M; Manninen V; Huttunen JK; Heinonen OP; Frick MH
    Diabetes Care; 1992 Jul; 15(7):820-5. PubMed ID: 1516498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The independent and combined effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM. A randomized controlled study.
    Dunstan DW; Mori TA; Puddey IB; Beilin LJ; Burke V; Morton AR; Stanton KG
    Diabetes Care; 1997 Jun; 20(6):913-21. PubMed ID: 9167099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up.
    Hanefeld M; Fischer S; Julius U; Schulze J; Schwanebeck U; Schmechel H; Ziegelasch HJ; Lindner J
    Diabetologia; 1996 Dec; 39(12):1577-83. PubMed ID: 8960845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
    Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study.
    Elkeles RS; Diamond JR; Poulter C; Dhanjil S; Nicolaides AN; Mahmood S; Richmond W; Mather H; Sharp P; Feher MD
    Diabetes Care; 1998 Apr; 21(4):641-8. PubMed ID: 9571357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intensive basic therapy decreases the need for drug treatment and improves glucose control: an important result of the diabetes intervention study].
    Hanefeld M; Schulze J; Fischer S; Rössger G; Lindner J; Groh G; Nehring A; Capek R
    Z Gesamte Inn Med; 1988 Dec; 43(24):700-2. PubMed ID: 2853497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factor analyses for macrovascular complication in nonobese NIDDM patients. Multiclinical Study for Diabetic Macroangiopathy (MSDM).
    Ito H; Harano Y; Suzuki M; Hattori Y; Takeuchi M; Inada H; Inoue J; Kawamori R; Murase T; Ouchi Y; Umeda F; Nawata H; Orimo H
    Diabetes; 1996 Jul; 45 Suppl 3():S19-23. PubMed ID: 8674883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological intervention: the antidiabetic approach.
    Melander A
    Eur J Clin Invest; 1998 Sep; 28 Suppl 2():23-5; discussion 25-6. PubMed ID: 9777324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of type II diabetes mellitus in population of Krakow].
    Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
    Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiorespiratory fitness, glycemic status, and mortality risk in men.
    Kohl HW; Gordon NF; Villegas JA; Blair SN
    Diabetes Care; 1992 Feb; 15(2):184-92. PubMed ID: 1547675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.
    Chiasson JL; Josse RG; Gomis R; Hanefeld M; Karasik A; Laakso M;
    JAMA; 2003 Jul; 290(4):486-94. PubMed ID: 12876091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia and glycemia in obese patients with NIDDM.
    Christiansen E; Schnider S; Palmvig B; Tauber-Lassen E; Pedersen O
    Diabetes Care; 1997 May; 20(5):881-7. PubMed ID: 9135961
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.